S-trityl protection of bis-amino bis-thiol (BAT) chelator enables flexible derivatisation and facile labelling with technetium-99m

Tetrahedron Letters

Volumn 44, Issue 12, 2003, Pages 2597-2600

  Cleynhens, Bernard J ^a   Bormans, Guy M ^a   Vanbilloen, Hubert P ^a   Vanderghinste, Dominique V ^a   Kieffer, Davy M ^a   De Groot, Tjibbe J ^a   Verbruggen, Alfons M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 ETHYLENEDICYSTEAMINE; 2 (2' HYDROXY 4' AMINOPHENYL) 1,3 BENZOTHIAZOLE; 2 NITROIMIDAZOLE; BENZOTHIAZOLE DERIVATIVE; CARBONYL DERIVATIVE; CHELATING AGENT; CYSTEAMINE DERIVATIVE; DESETHYLFLUMAZENIL; ETHYLENE; GLUCOSE; HYDROCHLORIC ACID; LIGAND; PROPYLENE; S,S' BIS TRITYL N TERT BUTYLOXYCARBONYL; TARTARIC ACID; TECHNETIUM 99M; THIOL DERIVATIVE; TRITYL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; HEATING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULE;

EID: 0037450905     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(03)00224-7     Document Type: Article

References (15)

1. Kung H.F., Meegalla S., Kung M.-P., Plössl K. Transition Met. Chem. 23:1998;531-536.
2. 99mTc-labelled benzamides as potential dopamine D2/D3 receptor imaging agents. Nicolini M., Bandoli G., Mazzi U. Technetium and Rhenium in Chemistry and Nuclear Medicine. 1999;497-502 Cortina International, Verona.
3. 1A receptor-binding complexes. Nicolini M., Bandoli G., Mazzi U. Technetium and Rhenium in Chemistry and Nuclear Medicine. 1999;393-399 Cortina International, Verona.
4. Chumpradit S., Choi R.S., Hou C., Acton P.D., Kung H.F. J. Labelled Comp. Radiopharm. 44:2001;S524-S526.
5. Chumpradit S., Kung M.-P., Mu M., Hou C., Kung H.F. J. Labelled Comp. Radiopharm. 39:1997;S437-S438.
6. Lever S.Z., Baidoo K.E., Kramer A.V., Burns H.D. Tetrahedron Lett. 29:1988;3219-3222.
7. Samnick S., Brandau W., Sciuk J., Steinstrasser J., Schober O. Nucl. Med. Biol. 22:1995;573-583.
8. Misra H.K., Virzi F., Hnatowich D.J., Wright G. Tetrahedron Lett. 30:1989;1885-1888.
9. Meegalla S.K., Plössl K., Kung M.P., Chumpradit S., Stevenson D.A., Kushner S.A., McElgin W.T., Mozley D., Kung H.F. J. Med. Chem. 40:1997;9-17.
10. Meltzer P.C., Blundell P., Jones A.G., Mahmood A., Garada B., Zimmerman R.E., Davison A., Holman B.L., Madras B.K. J. Med. Chem. 40:1997;1835-1844.
11. Blondeau P., Berse C., Gravel D. Can. J. Chem. 49:1967;49-52.
12. Vanbilloen H.P., Cleynhens B.J., Verbruggen A.M. Nucl. Med. Biol. 25:1998;569-575.
13. Okarvi S.M., Adriaens P., Verbruggen A. J. Labelled Comp. Radiopharm. 39:1997;853-874.
14. Oya S., Plössl K., Kung M.P., Stevenson D.A., Kung H.F. Nucl. Med. Biol. 25:1998;135-140.
15. Bormans G., Cleynhens B., Adriaens P., Vanbilloen H., De Roo M., Verbruggen A. Nucl. Med. Biol. 22:1995;339-349.